Anti-seizure medication
PreclinicalSmall molecule
Anti-seizure medication is one of 8 small molecule programs targeting Status Epilepticus. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
7
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
10 competitors in Status Epilepticus
#DrugCompanyPhaseTrials
1Keppra
UCBApproved
Ketalar
AAultman Health Foundation
Approved
Versed
CConrado Roberto Hoffmann Filho
Approved
Epidiolex
Jazz PharmaceuticalsApproved
Briviact
UCBPreclinical
Dilantin
VViatris Specialty LLC
Preclinical
Diacomit
BBiocodex
Preclinical
Anti-seizure medication
MMayo Clinic
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Anti-seizure medication. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- MMayo Clinic